Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea.

Abstract

BACKGROUND:

Obstructive sleep apnea (OSA) is associated with hypertension and the progression of chronic kidney disease (CKD). Renal sympathetic innervation contributes to either condition.

METHODS:

We investigated the effect of renal sympathetic denervation (RDN) on blood pressure (BP), renal perfusion, and neurohumoral responses during and after repetitive obstructive apneas in a pig model for OSA. BP, femoral artery, and renal artery flow were measured in 29 spontaneously breathing urethane-chloralose-anesthetized pigs. The effect of RDN (n = 14) and irbesartan (n = 3) was investigated. Repetitive tracheal occlusions for 2 minutes with applied negative tracheal pressure at -80 mbar were performed over 4 hours.

RESULTS:

Spontaneous breathing attempts during tracheal occlusion caused an intra-apneic breathing synchronous oscillating pattern of renal flow. Renal flow oscillations were > 2-fold higher compared with femoral flow that almost showed changes proportional to the BP alterations (2.9%/mm Hg vs. 1.3%/mm Hg; P < 0.0001). A marked postapneic BP rise from 102 ± 3 to 172 ± 8 mm Hg (P < 0.00001) was associated with renal hypoperfusion (from 190 ± 24 to 70 ± 20 ml/min; P < 0.00001) occurring after application of obstructive respiratory events. RDN, but not irbesartan, inhibited postapneic BP rises and renal hypoperfusion and attenuated increased plasma renin activity and aldosterone concentration induced by repetitive tracheal occlusions. Additionally, increased urinary protein/creatinine ratio was significantly reduced by RDN, whereas intra-apneic hemodynamic changes or blood gases were not modified by RDN.

CONCLUSIONS:

Repetitive obstructive respiratory events result in postapneic BP rises and renal hypoperfusion, as well as neurohumoral responses and increased protein/creatinine ratio. These changes are mainly sympathetically driven because they could be attenuated by RDN.

• Authors: Dominik Linz, Felix Mahfoud, Benedikt Linz, Mathias Hohl, Stephan H Schirmer, Klaus J Wirth, Michael Böhm
• Journal: American journal of hypertension (Am J Hypertens) Vol. 27 Issue 10 Pg. 1293-300 (Oct 2014) ISSN: 1941-7225 [Electronic] United States
• PMID: 24622919 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: [email protected].

Chemical References

• Antihypertensive Agents
• Biphenyl Compounds
• Tetrazoles
• Aldosterone
• Creatinine
• Renin
• Irbesartan

Topics

• Aldosterone (blood)
• Animals
• Antihypertensive Agents (pharmacology)
• Biphenyl Compounds (pharmacology)
• Blood Pressure (drug effects, physiology)
• Creatinine (urine)
• Disease Models, Animal
• Hypertension (complications, physiopathology)
• Irbesartan
• Kidney (blood supply, drug effects, innervation)
• Proteinuria
• Renal Artery (drug effects, physiopathology)
• Renin (blood)
• Sleep Apnea, Obstructive (complications, physiopathology)
• Sympathectomy
• Tetrazoles (pharmacology)